Biotechnology Healthcare - November/December 2008 - (Page TCover1)

CLINICAL BRIEFS Tumor Necrosis Factor Inhibitors A review of dosing patterns and related economic considerations By Joseph Flood, MD, FACR President, Musculoskeletal Medical Specialists Inc.; Clinical faculty member, The Ohio State University College of Medicine and Public Health, Columbus With a managed care analysis by Douglas S. Burgoyne, PharmD President, Scrip World, Salt Lake City, Utah Supplement to Volume 5, No. 4 Supplement 4 November 2008 This publication is supported by Amgen Table of Contents for the Digital Edition of Biotechnology Healthcare - November/December 2008Biotechnology Healthcare - November/December 2008OpenersContentsEditorial/David B. Nash, MD, MBAPersonalized MedicineInflammatory Bowel DiseaseDrugTrackVEBAs: The Great Benefits Hand-offWill 2009 Be the Year for Follow-on Biologics?Bio-Re: A Reinsurance Plan for Specialty DrugsManaging Cost of Hemophilia Involves More Than Just MedicationWhen You’re Insured but Worse off Than Without InsuranceSpecialty PharmacyEmployer to EmployerTrendsBiotechnology Healthcare - November/December 2008Biotechnology Healthcare - November/December 2008 - Biotechnology Healthcare - November/December 2008 (Page Cover1)Biotechnology Healthcare - November/December 2008 - Biotechnology Healthcare - November/December 2008 (Page Cover2)Biotechnology Healthcare - November/December 2008 - Biotechnology Healthcare - November/December 2008 (Page i)Biotechnology Healthcare - November/December 2008 - Biotechnology Healthcare - November/December 2008 (Page ii)Biotechnology Healthcare - November/December 2008 - Openers (Page 1)Biotechnology Healthcare - November/December 2008 - Contents (Page 2)Biotechnology Healthcare - November/December 2008 - Contents (Page 3)Biotechnology Healthcare - November/December 2008 - Editorial/David B. Nash, MD, MBA (Page 4)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 5)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 6)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 7)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 8)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 9)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 10)Biotechnology Healthcare - November/December 2008 - Personalized Medicine (Page 11)Biotechnology Healthcare - November/December 2008 - Inflammatory Bowel Disease (Page 12)Biotechnology Healthcare - November/December 2008 - Inflammatory Bowel Disease (Page 13)Biotechnology Healthcare - November/December 2008 - DrugTrack (Page 14)Biotechnology Healthcare - November/December 2008 - DrugTrack (Page 15)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 16)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 17)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 18)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 19)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 20)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 21)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 22)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 23)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 24)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 25)Biotechnology Healthcare - November/December 2008 - VEBAs: The Great Benefits Hand-off (Page 26)Biotechnology Healthcare - November/December 2008 - Will 2009 Be the Year for Follow-on Biologics? (Page 27)Biotechnology Healthcare - November/December 2008 - Will 2009 Be the Year for Follow-on Biologics? (Page 28)Biotechnology Healthcare - November/December 2008 - Will 2009 Be the Year for Follow-on Biologics? (Page 29)Biotechnology Healthcare - November/December 2008 - Will 2009 Be the Year for Follow-on Biologics? (Page 30)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 31)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 32)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 33)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 34)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 35)Biotechnology Healthcare - November/December 2008 - Bio-Re: A Reinsurance Plan for Specialty Drugs (Page 36)Biotechnology Healthcare - November/December 2008 - Managing Cost of Hemophilia Involves More Than Just Medication (Page 37)Biotechnology Healthcare - November/December 2008 - Managing Cost of Hemophilia Involves More Than Just Medication (Page 38)Biotechnology Healthcare - November/December 2008 - Managing Cost of Hemophilia Involves More Than Just Medication (Page 39)Biotechnology Healthcare - November/December 2008 - Managing Cost of Hemophilia Involves More Than Just Medication (Page 40)Biotechnology Healthcare - November/December 2008 - When You’re Insured but Worse off Than Without Insurance (Page 41)Biotechnology Healthcare - November/December 2008 - When You’re Insured but Worse off Than Without Insurance (Page 42)Biotechnology Healthcare - November/December 2008 - When You’re Insured but Worse off Than Without Insurance (Page 43)Biotechnology Healthcare - November/December 2008 - Specialty Pharmacy (Page 44)Biotechnology Healthcare - November/December 2008 - Specialty Pharmacy (Page 45)Biotechnology Healthcare - November/December 2008 - Employer to Employer (Page 46)Biotechnology Healthcare - November/December 2008 - Employer to Employer (Page 47)Biotechnology Healthcare - November/December 2008 - Trends (Page 48)Biotechnology Healthcare - November/December 2008 - Trends (Page TCover1)Biotechnology Healthcare - November/December 2008 - Trends (Page T1)Biotechnology Healthcare - November/December 2008 - Trends (Page T2)Biotechnology Healthcare - November/December 2008 - Trends (Page T3)Biotechnology Healthcare - November/December 2008 - Trends (Page T4)Biotechnology Healthcare - November/December 2008 - Trends (Page T5)Biotechnology Healthcare - November/December 2008 - Trends (Page U1)Biotechnology Healthcare - November/December 2008 - Trends (Page U2)Biotechnology Healthcare - November/December 2008 - Trends (Page U3)Biotechnology Healthcare - November/December 2008 - Trends (Page U4)Biotechnology Healthcare - November/December 2008 - Trends (Page U5)Biotechnology Healthcare - November/December 2008 - Trends (Page U6)Biotechnology Healthcare - November/December 2008 - Trends (Page Cover3)Biotechnology Healthcare - November/December 2008 - Trends (Page Cover4)http://www.nxtbook.com/nxtbooks/medimedia/bh_20091011http://www.nxtbook.com/nxtbooks/medimedia/bh_200908http://www.nxtbook.com/nxtbooks/medimedia/bh_200906http://www.nxtbook.com/nxtbooks/medimedia/bh_200904http://www.nxtbook.com/nxtbooks/medimedia/bh_20081112http://www.nxtbook.com/nxtbooks/medimedia/bh_20080910http://www.nxtbook.com/nxtbooks/medimedia/bh_20080708http://www.nxtbook.com/nxtbooks/medimedia/bh_200806http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.